Search results
29 kwi 2022 · Tumid lupus erythematosus (TLE), also known as lupus erythematosus tumidus, is a highly photosensitive form of cutaneous lupus erythematosus (cutaneous LE) that classically presents with erythematous, edematous plaques ( picture 1A-C ). Traditionally, TLE has been classified as a subset of chronic cutaneous LE.
1 sie 2003 · * The major clinical, histopathologic, immunohistochemical, and serologic findings that distinguish tumid lupus erythematosus (LE) from selected cutaneous disorders are presented. DIF = direct immunofluorescente; SLE = systemic lupus erythematosus; S & D = superficial and deep; lcv = necrotizing (leukocytoclastic) vasculitis; I = interstitial ...
Tumid lupus erythematosus is a rare, but distinctive entity in which patients present with edematous erythematous plaque. [2]Lupus erythematosus tumidus (LET) was reported by Henri Gougerot and Burnier R. in 1930. It is a photosensitive skin disorder, a different subtype of cutaneous lupus erythematosus (CLE) from discoid lupus erythematosus (DLE) or subacute CLE (SCLE). [3]
Cutaneous lupus erythematosus (LE) is a diverse group of autoimmune connective tissue disorders localised to the skin that can be associated with systemic lupus erythematosus (SLE) to varying degrees.
8 kwi 2024 · Tumid lupus erythematosus (TLE) is a rare, chronic relapsing, photosensitive dermatosis of indolent clinical behavior [9,10]. TLE has been traditionally classified under the umbrella definition of chronic cutaneous lupus erythematosus (CCLE) .
19 lut 2023 · Tumid lupus erythematosus (TLE) is a rare disorder that affects sun-exposed areas of the skin. It is characterized by smooth pink to violet pimples that typically do not leave scars. Health experts consider TLE to be a rare type of chronic cutaneous lupus erythematosus.
Tumid lupus erythematosus (TLE) is a rare variant of chronic cutaneous lupus erythematosus rarely associated with systemic lupus erythematosus (SLE). Patients with TLE and risk factors for SLE development (African-American, women age 15–55, other coexisting autoimmune disease, SLE in a first-degree family member) can benefit from SLE ...
